(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REVMED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REVMED

ST13

US500000098182283

Class

5, 42, 44

Filing

98182283

Registration

7941121

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

09/10/2025

Trademark type

Word

Nice classes

5, 42, 44

Filing date

09/15/2023

Registration date

09/09/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/09/2025

Last transaction

09/10/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/12/2024

First use in commerce

01/12/2024

Drawing code

4

Owner type

03

Owner location

Redwood City, CA

Examiner

SUE, ABIGAIL

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Revolution Medicines, Inc.

Representatives

Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and oncological diseases and disorders; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in the treatment of immunological diseases and disorders

Class 42

Pharmaceutical research and development; drug discovery services; Providing information about medical and scientific research via a website

Class 44

Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosismanagementtreatment options in the field of oncological and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/09/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/18/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/18/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/18/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/15/2025

IUAF

USE AMENDMENT FILED

12/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

12/10/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/26/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/11/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

06/10/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/10/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

06/10/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/10/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

06/06/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

05/28/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/14/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/13/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/13/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/13/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/13/2024

DOCK

ASSIGNED TO EXAMINER

05/09/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/04/2023

NWAP

NEW APPLICATION ENTERED

09/19/2023

Continuous trademark protection

Get notified about every new filing that threatens REVMED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.